Ionian Technologies Gets Gates Funding for MDx Platform | GenomeWeb

NEW YORK (GenomeWeb News) – Ionian Technologies today said that it has received additional funding from the Bill & Melinda Gates Foundation to continue developing a molecular diagnostics platform designed for use in the developing world.

The San Diego-based firm said that its total commitment from the Gates foundation has risen to $3 million over two years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.

A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.

Researchers report in Nature this week that farming led to genomic adaptations in humans.

The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.